Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

Clinical Infectious Diseases

Volumn 23, Issue 5, 1996, Pages 964-972

  Anaissie, Elias J ^a   Darouiche, Rabih O ^b   Abi Said, Dima ^b   Uzun, Omrum ^b   Mera, Jorge ^b   Gentry, Layne O ^b   Williams, Temple ^b   Kontoyiannis, Dimitrios P ^b   Karl, Cynthia L ^b   Bodey, Gerald P ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; CORTICOSTEROID; FLUCONAZOLE;

ABDOMINAL ABSCESS; ARTICLE; BLOOD CULTURE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FUNGUS IDENTIFICATION; GASTROINTESTINAL SYMPTOM; GRAM STAINING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PERITONITIS; PRIORITY JOURNAL; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RASH; SURVIVAL; URINARY TRACT INFECTION; WOUND INFECTION;

EID: 10344251462     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.5.964     Document Type: Article

References (14)

1. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994;19(suppl 1):S33-40.
2. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29(suppl A):19-24.
3. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-5.
4. Bodey GP. Hematogenous and major organ candidiasis. In: Bodey GP, ed. Candidiasis: pathogenesis, diagnosis and treatment. 2nd ed. New York: Raven Press, 1993:279-329.
5. Anaissie E, Solomkin JS. Fungal infection. In: Wilmore DW, Brennan MF, Harken AH, Holcroft JW, Meakins JL, eds. Care of the surgical patient. Vol. 2. New York: Scientific American, 1994:1-19.
6. Meunier F. Fungal infections in cancer patients. Cancer Invest 1991;9:151-8.
7. Solomkin JS, Flohr AM, Simmons RL. Indications for therapy for fungemia in postoperative patients. Arch Surg 1982;117:1272-5.
8. Patterson TF, Andriole VT. The role of liposomal amphotericin B in the treatment of systemic fungal infections. Eur J Cancer Clin Oncol 1989;25(suppl 2):S63-8.
9. Gallis HA, Drew RH, Pickard WW. Amphotericin B: 30 years of clinical experience. Rev Infect Dis 1990;12:308-29.
10. Walsh TJ, Aoki S, Mechinaud F, et al. Effects of preventive, early, and late antifungal chemotherapy with fluconazole in different granulocytopenic models of experimental disseminated candidiasis. J Infect Dis 1990;161:755-60.
11. Van't Wout JW, Mattie H, van Furth R. A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections. J Antimicrob Chemother 1988;21:665-72.
12. Kujath P, Lerch K. Secondary mycosis in surgery: treatment with fluconazole. Infection 1989;17:111-7.
13. Nolla-Salas J, Leon C, Torres-Rodriguez JM, Martin E, Sitges-Serra A. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 1992;14:952-4.
14. Graninger W, Presteril E, Schneeweiss B, Teleky B, Georgopoulos A. Treatment of Candida albicans fungemia with fluconazole. J Infect Dis 1993;26:133-46.